etoposide has been researched along with mdv 3100 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Brookes, PS; Germain, TM; Huwaimel, B; Kinarivala, N; Miller, J; Pappas, D; Trippier, PC; Verma, K; Wang, H | 1 |
| Aimono, E; Hongo, H; Kosaka, T; Mikami, S; Nishihara, H; Oya, M; Watanabe, K | 1 |
| Hwang, SY; Jeon, KH; Jo, H; Jung, AR; Kwon, Y; Na, Y; Park, S; Seo, SH; Shin, JH | 1 |
3 other study(ies) available for etoposide and mdv 3100
| Article | Year |
|---|---|
Synthesis and Antineoplastic Evaluation of Mitochondrial Complex II (Succinate Dehydrogenase) Inhibitors Derived from Atpenin A5.
Topics: Animals; Antineoplastic Agents; Benzamides; Catalytic Domain; Cell Line, Tumor; Electron Transport; Etoposide; HEK293 Cells; Humans; Mice; Models, Molecular; Nitriles; Phenylthiohydantoin; Pyridones; Quantitative Structure-Activity Relationship; Succinate Dehydrogenase; Swine | 2017 |
Japanese Case of Enzalutamide-Resistant Prostate Cancer Harboring a SPOP Mutation With Scattered Allelic Imbalance: Response to Platinum-Based Therapy.
Topics: Aged; Allelic Imbalance; Benzamides; Carboplatin; Drug Resistance, Neoplasm; Etoposide; Humans; Japan; Male; Mutation; Nitriles; Nuclear Proteins; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Repressor Proteins; Treatment Outcome | 2019 |
Synthesis and evaluation of 7-(3-aminopropyloxy)-substituted flavone analogue as a topoisomerase IIα catalytic inhibitor and its sensitizing effect to enzalutamide in castration-resistant prostate cancer cells.
Topics: Androgen Antagonists; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Etoposide; Flavones; Humans; Male; Nitriles; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen | 2023 |